I have really enjoyed working at Trust. It has been great working with collaborative staff who are dedicated to helping all people. The Trust team works closely to ensure that all clients' needs...
Trust Therapeutics
(6)
Photos
IMMEDIATE Therapeutics, based in Boston, is focused on developing IMT-358, an investigational drug aimed at providing metabolic protection to the heart muscle during the critical early hours of an acute coronary syndrome (ACS) event. The FDA has designated IMT-358 as a Breakthrough Therapy to potentially reduce mortality risks, hospitalization for heart failure, and cardiac arrest associated with heart attacks.
With approximately 7.5 million patients presenting with chest pain symptomatic of ACS annually in the United States, IMMEDIATE aims to intervene early to enhance clinical outcomes and quality of life for patients. The efficacy of IMT-358 is currently being evaluated in a planned pivotal phase 3 trial, emphasizing the importance of timely management during cardiac emergencies.
Generated from the website
Also at this address
Reviews

I would not recommend this establishment. I reached out to them seeking therapy. I was contacted and provided all my information they requested. I was told that they took my insurance and they...

At first I was glad I found someone so quickly here who fit my criteria, but in what was supposed to be our first official session, I tried to explain that some of ways she said she wanted to...
I am thankful to Trust and my therapist for working with me. They have been accommodating and inclusive and even take my insurance.
I do not recommend Trust Therapeutics. They are impossible to reach when you have a question as their phone line goes straight to an automated voice message system that will give you an email and...
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.